Press release
Radiopharmaceuticals Market Worth USD 8.77 billion by 2023 with CAGR of 9.45% during 2014 - 2023 | Bracco Imaging S.p.A, IBA Molecular Imaging India Private Limited, Wipro GE Healthcare Pvt Ltd, Bayer HealthCare Pharmaceuticals LLC, Nordion Inc, Lantheus
A research study titled, “Radiopharmaceuticals Market by type, procedural volumes and application- global industry analysis and forecast to 2023” published by crystal market research.Competitive Analysis:
The leading players in the market are Bracco Imaging S.p.A, IBA Molecular Imaging India Private Limited, Wipro GE Healthcare Pvt Ltd, Bayer HealthCare Pharmaceuticals LLC, Nordion Inc, Lantheus Medical Imaging Inc, Cardinal Health, Advanced Accelerator Applications and Mallinckrodt.
Click to Request a Sample:
https://www.crystalmarketresearch.com/report-sample/HC01517
Regional Outlook and Trend Analysis
Geographically, the market is fragmented into Europe, North America, Asia-Pacific, and the Rest of the World. North America is accounted for the biggest share, trailed by Asia-Pacific and Europe In 2016. The Asia-Pacific locale is foreseen to develop at the most elevated CAGR amid the estimate time frame. This high development can be ascribed to the establishment of PET scanners in India and activities by the legislature of the Asian nations to advance health among others.
Industry Outlook & Trend Analysis:
The global Radiopharmaceuticals market was worth USD 3.89 billion in 2014 and is expected to reach approximately USD 8.77 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 9.45% during the forecast period.
The market is right now in its development phase driven by expanding number of disease cases and increasing awareness about nuclear medication. Radiopharmaceuticals are pharmaceutical formulations involving radioactive isotopes that are useful as a part of analysis and therapeutics. They are basic and small substances that contain a radioactive substance that is useful as a part of the treatment of cancer and neurological and cardiac disorders. The regular chemotherapy techniques are being supplanted by more advantageous helpful radiopharmaceuticals for oncology and cancer treatment, which opens up new roads in the radiopharmaceuticals market.
Type Outlook and Trend Analysis
On the basis of type, the market is fragmented into therapeutic and diagnostic. The diagnostic portion represented the biggest share of the nuclear medicine market. The diagnostic portion is additionally fragmented into PET and SPECT. In 2016, the SPECT section represented the biggest share of the radiopharmaceuticals diagnostic market. The therapeutic fragment is additionally divided into brachytherapy, alpha emitters, and beta emitters.
Browse Full Report with TOC@
https://www.crystalmarketresearch.com/report/radiopharmaceuticals-market
Application Outlook and Trend Analysis
Based on application, the radiopharmaceuticals market is fragmented into PET, SPECT and therapeutic applications. In 2016, the cardiology application section represented the biggest share of the atomic medication SPECT applications market. The atomic radiopharmaceuticals PET applications market was ruled by the oncology section, while the radiopharmaceuticals therapeutic applications market was ruled by the thyroid application fragment.
By Procedural Volumes
Diagnostic Procedures
SPECT Radiopharmaceuticals
PET Radiopharmaceuticals
Therapeutic Procedures
Beta Emitters
Alpha Emitters
Brachytherapy
Table of Contents:
Introduction
Executive Summary
Market Overview
Market Analysis by Region
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
North America (U.S, Canada, Mexico)
Europe (Germany, France, UK, Italy, Spain, Rest of Europe)
Asia-Pacific (Japan, China, Australia, India, South Korea, Rest of Asia-Pacific)
Rest of the World (Brazil, South Africa, Saudi Arabia, Turkey, United Arab Emirates, Others)
Check discount offer for Report click on the link
https://www.crystalmarketresearch.com/check-discount/HC01517
Crystal offers one stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customized research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy.
304 South Jones Blvd, Suite 1896,
Las Vegas NV 89107,
United States
Toll Free: +1-888-213-4282
Email: sales@crystalmarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Radiopharmaceuticals Market Worth USD 8.77 billion by 2023 with CAGR of 9.45% during 2014 - 2023 | Bracco Imaging S.p.A, IBA Molecular Imaging India Private Limited, Wipro GE Healthcare Pvt Ltd, Bayer HealthCare Pharmaceuticals LLC, Nordion Inc, Lantheus here
News-ID: 1115767 • Views: …
More Releases from Crystal Market Research - Healthcare

Viral Vector And Plasmid Dna Manufacturing Market Outlook 2019 | Business Develo …
Crystal Market Research Present Advance research on - Viral Vector And Plasmid Dna Manufacturing Market, approximates that the Viral Vector And Plasmid Dna Manufacturing Industry size is anticipated to flourish at a significant CAGR in the future.
The Viral Vector and Plasmid DNA Manufacturing Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Viral vectors and plasmid DNA manufacturing usually incorporates…

Medical Digital Imaging Systems Market | Research Report 2019-2025 | Major Compa …
Crystal Market Research Present Advance research on "Medical Digital Imaging Systems Market", approximates that the Medical Digital Imaging Systems Industry size is anticipated to flourish at a significant CAGR in the future.
The Medical Imaging is the process and technique of making the visual portrayals of the inside of the body for the purpose of medical intervention and clinical analysis, just as visual portrayal of the functioning of certain tissues (physiology)…

Medical Device Complaint Management Market | Research Report 2019-2025 | Major C …
Crystal Market Research Present Advance research on "Medical Device Complaint Management Market", approximates that the Medical Device Complaint Management Industry size is anticipated to flourish at a significant CAGR in the future.
The manufacturers of medical gadget must keep record and also track the complaints of customer as per the Quality System Regulation (QSR) characterized in the 21 CFR Part 820. Furthermore, the FDA Part 803 guidelines need the firms…

Veterinary Molecular Diagnostics Market | Research Report 2019-2025 | Major Comp …
The Universal Veterinary Molecular Diagnostics Market is anticipated to observe supported development over the foreseen period. The major development factor for the growth of Veterinary Molecular Diagnostics is the positive development in the beverage sector. Moreover, expanding canned food preference and increment in extra cash of the customers is the primary factors which are driving the market. Moreover, high recovery and recycling rate of the metal cans is anticipated to…
More Releases for Radiopharmaceuticals
Radiopharmaceuticals Market Size, Share | Forecast - 2033
The new report published by The Business Research Company, titled Radiopharmaceuticals Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.
As per the report, the radiopharmaceuticals market size has grown steadily in recent years. It will grow from $6.46 billion in 2023 to…
Radiopharmaceuticals Market - Harnessing the Power of Radiopharmaceuticals for P …
Newark, New Castle, USA: The "Radiopharmaceuticals Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Radiopharmaceuticals Market: https://www.growthplusreports.com/report/radiopharmaceuticals-market/7842
This latest report researches the industry structure, sales, revenue, price and…
Nuclear Medicine/Radiopharmaceuticals Market Growing by Convenience of Radiophar …
Nuclear Medicine/Radiopharmaceuticals Market Outlook 2022-2029
The Nuclear Medicine/Radiopharmaceuticals Market research offers complete knowledge and information on the market's flowing landscape, what is now available on the market, upcoming trends, market expectations, the competitive environment, and methods that may be used to outperform competitors.
Market Analysis and Size
The Nuclear Medicine/Radiopharmaceuticals Market is currently valued at US$ 10.16 Billion and is projected to register 9.90% CAGR through 2029.
Gets a Sample Copy of the Nuclear…
Global Radiopharmaceuticals Market Global Radiopharmaceuticals Sales Report 2020
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Global Radiopharmaceutical Market Overview
1.1 Current Market Scenario
1.2 Diagnostic & Therapeutic Radiopharmaceuticals
1.3 Global Radiopharmaceticals Clinical Pipeline Overview
2. Global Radiopharmaceuticals Market Dynamics
3. Radioisotopes Used in Radiopharmaceuticals
4. EMA Guidelines for Radiopharmaceuticals
4.1 Physico-Chemical, Biological or Microbiological Tests of Medicinal Products
4.2 Toxicological & Pharmacological Tests
4.3 Clinical Documentation
4.4 Radiation…
Nuclear Medicine/Radiopharmaceuticals Market
Radiopharmaceuticals are unique medicinal formulations that contain radioisotopes and are used in clinical applications for diagnosis and therapy. The facilities and procedures for production, use, and storage of radiopharmaceuticals are subject to license approval either by national or regional authorities such as Nuclear Regulatory Commission (NRC) of U.S, Atomic Energy Commission (AEC) of U.S., or Atomic Energy Regulatory Board (AERB) of India. Licensing includes compliance regarding pharmaceutical preparations and use…
Global Radiopharmaceuticals Market Insight
Radioisotopes are radioactive isotopes having an unstable balance of atomic nucleus. Radioisotopes are produced either by using nuclear research reactor or by using cyclotron. These isotopes emit energy in the form of alpha, beta or gamma when changed to a stable nature. The gamma rays, thus emitted are used in Nuclear medicine, specifically in medical diagnostics. In this field, the radiation is used to provide diagnostic information about a…